遺伝子組み換え骨髄mesenehymal幹細胞は異種移植凝固障害のin vitroモデルにおける凝固を調節することができる【Powered by NICT】
Jing Wang(Guiyang Medical University), Dou Ke-feng(Xijing Hospital), Kaishan Tao(Xijing Hospital), Ben Ma, Ji Hongchen, Desheng Wang(The Second Affiliated Hospital of Bengbu Medical College), Jianlin Wang(Southwest University of Science and Technology), Xiao Li(Shandong University of Traditional Chinese Medicine), Zhang Zhuochao
Unknown
January 1, 2015
Cited by 0
Related Papers
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
|International Journal of Clinical Practice|2008|226
c-Myc-Mediated Epigenetic Silencing of MicroRNA-101 Contributes to Dysregulation of Multiple Pathways in Hepatocellular Carcinoma
|Hepatology|2013|163
Modified human uterus transplantation using ovarian veins for venous drainage: the first report of surgically successful robotic-assisted uterus procurement and follow-up for 12 months
|Fertility and Sterility|2017|160
Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling
|Hepatology|2011|118
Long Non-coding RNA URHC Regulates Cell Proliferation and Apoptosis via ZAK through the ERK/MAPK Signaling Pathway in Hepatocellular Carcinoma
|International Journal of Biological Sciences|2014|111